The European Commission has followed the United States in approving the world’s first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday. “This authorization for Arexvy means eligible adults can be vaccinated against RSV Continue Reading
Yoruba News
Weekend Treat
Trending Now
Recent Posts
Categories
Archives
iframe: google.com, pub-5160901092443552, DIRECT, f08c47fec0942fa0
This is the head of your page
This is the body of your page.